• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国 1980 年至 2008 年的妊娠期前和妊娠期糖尿病模拟估计值。

Simulated estimates of pre-pregnancy and gestational diabetes mellitus in the US: 1980 to 2008.

机构信息

Department of Industrial & Systems Engineering, North Carolina State University, Raleigh, North Carolina, United States of America.

出版信息

PLoS One. 2013 Sep 5;8(9):e73437. doi: 10.1371/journal.pone.0073437. eCollection 2013.

DOI:10.1371/journal.pone.0073437
PMID:24039941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3764167/
Abstract

PURPOSE

To simulate national estimates of prepregnancy and gestational diabetes mellitus (GDM) in non-Hispanic white (NHW) and non-Hispanic black (NHB) women.

METHODS

Prepregnancy diabetes and GDM were estimated as a function of age, race/ethnicity, and body mass index (BMI) using South Carolina live singleton births from 2004-2008. Diabetes risk was applied to a simulated population. Age, natality and BMI were assigned to women according to race- and age-specific US Census, Natality and National Health and Nutrition Examination Surveys (NHANES) data, respectively.

RESULTS

From 1980-2008, estimated GDM prevalence increased from 4.11% to 6.80% [2.68% (95% CI 2.58%-2.78%)] and from 3.96% to 6.43% [2.47% (95% CI 2.39%-2.55%)] in NHW and NHB women, respectively. In NHW women prepregnancy diabetes prevalence increased 0.90% (95% CI 0.85%-0.95%) from 0.95% in 1980 to 1.85% in 2008. In NHB women from 1980 through 2008 estimated prepregnancy diabetes prevalence increased 1.51% (95% CI 1.44%-1.57%), from 1.66% to 3.16%.

CONCLUSIONS

Racial disparities in diabetes prevalence during pregnancy appear to stem from a higher prevalence of prepregnancy diabetes, but not GDM, in NHB than NHW.

摘要

目的

模拟非西班牙裔白人(NHW)和非西班牙裔黑人(NHB)女性的孕前和妊娠期糖尿病(GDM)的全国估计数。

方法

利用 2004 年至 2008 年南卡罗来纳州的活产单胎数据,根据年龄、种族/族裔和体重指数(BMI)来估计孕前糖尿病和 GDM。将糖尿病风险应用于模拟人群。根据种族和年龄特定的美国人口普查、出生率和国家健康和营养检查调查(NHANES)数据,为女性分配年龄、出生率和 BMI。

结果

1980 年至 2008 年,估计的 GDM 患病率从 4.11%增加到 6.80%[2.68%(95%CI 2.58%-2.78%)]和从 3.96%增加到 6.43%[2.47%(95%CI 2.39%-2.55%)],分别在 NHW 和 NHB 女性中。在 NHW 女性中,孕前糖尿病的患病率从 1980 年的 0.95%增加了 0.90%(95%CI 0.85%-0.95%),到 2008 年的 1.85%。在 NHB 女性中,1980 年至 2008 年期间,估计的孕前糖尿病患病率增加了 1.51%(95%CI 1.44%-1.57%),从 1.66%增加到 3.16%。

结论

妊娠期间糖尿病患病率的种族差异似乎源于 NHB 女性的孕前糖尿病患病率高于 NHW 女性,但 GDM 患病率并非如此。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228c/3764167/9b1435de1d12/pone.0073437.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228c/3764167/ba203addbcae/pone.0073437.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228c/3764167/9b1435de1d12/pone.0073437.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228c/3764167/ba203addbcae/pone.0073437.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228c/3764167/9b1435de1d12/pone.0073437.g002.jpg

相似文献

1
Simulated estimates of pre-pregnancy and gestational diabetes mellitus in the US: 1980 to 2008.美国 1980 年至 2008 年的妊娠期前和妊娠期糖尿病模拟估计值。
PLoS One. 2013 Sep 5;8(9):e73437. doi: 10.1371/journal.pone.0073437. eCollection 2013.
2
Impact of maternal diabetes on birthweight is greater in non-Hispanic blacks than in non-Hispanic whites.母亲患糖尿病对新生儿体重的影响在非西班牙裔黑种人中比在非西班牙裔白种人中更大。
Diabetologia. 2012 Apr;55(4):971-80. doi: 10.1007/s00125-011-2430-z. Epub 2012 Jan 12.
3
The Effects of Race and Ethnicity on the Risk of Large-for-Gestational-Age Newborns in Women Without Gestational Diabetes by Prepregnancy Body Mass Index Categories.按孕前体重指数类别划分,种族和族裔对无妊娠期糖尿病女性中大于胎龄儿新生儿风险的影响。
Matern Child Health J. 2017 Aug;21(8):1643-1654. doi: 10.1007/s10995-016-2256-x.
4
Racial and ethnic disparities in extremes of fetal growth after gestational diabetes mellitus.妊娠糖尿病后胎儿生长极端情况中的种族和族裔差异。
Diabetologia. 2015 Feb;58(2):272-81. doi: 10.1007/s00125-014-3420-8. Epub 2014 Oct 24.
5
Maternal pre-pregnancy weight and gestational weight gain and their association with birthweight with a focus on racial differences.孕产妇孕前体重和孕期体重增加及其与出生体重的关系,重点关注种族差异。
Matern Child Health J. 2013 Jan;17(1):85-94. doi: 10.1007/s10995-012-0950-x.
6
Proportion of gestational diabetes mellitus attributable to overweight and obesity among non-Hispanic black, non-Hispanic white, and Hispanic women in South Carolina.南卡罗来纳州非西班牙裔黑人、非西班牙裔白人及西班牙裔女性中,由超重和肥胖导致的妊娠期糖尿病比例。
Matern Child Health J. 2014 Oct;18(8):1919-26. doi: 10.1007/s10995-014-1437-8.
7
Racial and ethnic disparities in diabetes risk after gestational diabetes mellitus.妊娠糖尿病后糖尿病风险的种族和民族差异。
Diabetologia. 2011 Dec;54(12):3016-21. doi: 10.1007/s00125-011-2330-2. Epub 2011 Oct 21.
8
Quantifying the impact of gestational diabetes mellitus, maternal weight and race on birthweight via quantile regression.通过分位数回归量化妊娠期糖尿病、产妇体重和种族对出生体重的影响。
PLoS One. 2013 Jun 10;8(6):e65017. doi: 10.1371/journal.pone.0065017. Print 2013.
9
The Impact of Maternal Diabetes, Obesity and Race on Infant Birth Weights in South Dakota.南达科他州孕产妇糖尿病、肥胖和种族对婴儿出生体重的影响。
S D Med. 2017 Feb;70(2):61-66.
10
Increasing prevalence of diabetes during pregnancy in South Carolina.南卡罗来纳州孕期糖尿病患病率不断上升。
J Womens Health (Larchmt). 2015 Apr;24(4):316-23. doi: 10.1089/jwh.2014.4968. Epub 2015 Mar 18.

引用本文的文献

1
Increasing prevalence of diabetes during pregnancy in South Carolina.南卡罗来纳州孕期糖尿病患病率不断上升。
J Womens Health (Larchmt). 2015 Apr;24(4):316-23. doi: 10.1089/jwh.2014.4968. Epub 2015 Mar 18.

本文引用的文献

1
Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis.采用新的 IADPSG 指南进行妊娠期糖尿病筛查:成本效益分析。
Am J Obstet Gynecol. 2012 Oct;207(4):326.e1-9. doi: 10.1016/j.ajog.2012.06.048. Epub 2012 Jun 29.
2
Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children.妊娠并发症与中年时计算的心血管疾病风险和心血管危险因素的关联:阿冯纵向父母与子女研究。
Circulation. 2012 Mar 20;125(11):1367-80. doi: 10.1161/CIRCULATIONAHA.111.044784. Epub 2012 Feb 17.
3
Cost effectiveness of saxagliptin and metformin versus sulfonylurea and metformin in the treatment of type 2 diabetes mellitus in Germany: a Cardiff diabetes model analysis.
在德国,治疗 2 型糖尿病中,沙格列汀和二甲双胍相较于磺脲类药物和二甲双胍的成本效益:卡迪夫糖尿病模型分析。
Clin Drug Investig. 2012 Mar 1;32(3):189-202. doi: 10.2165/11597060-000000000-00000.
4
Impact of maternal diabetes on birthweight is greater in non-Hispanic blacks than in non-Hispanic whites.母亲患糖尿病对新生儿体重的影响在非西班牙裔黑种人中比在非西班牙裔白种人中更大。
Diabetologia. 2012 Apr;55(4):971-80. doi: 10.1007/s00125-011-2430-z. Epub 2012 Jan 12.
5
Cost-effectiveness of insulin glargine versus NPH insulin for the treatment of Type 2 diabetes mellitus, modeling the interaction between hypoglycemia and glycemic control in Switzerland.甘精胰岛素与中性鱼精蛋白锌胰岛素治疗2型糖尿病的成本效益:瑞士低血糖与血糖控制相互作用的模型研究
Int J Clin Pharmacol Ther. 2011 Mar;49(3):217-30. doi: 10.5414/cpp49217.
6
The cost effectiveness of rapid-acting insulin aspart compared with human insulin in type 2 diabetes patients: an analysis from the Japanese third-party payer perspective.从日本第三方支付者角度看,与人胰岛素相比,速效门冬胰岛素在 2 型糖尿病患者中的成本效果。
J Med Econ. 2011;14(1):36-46. doi: 10.3111/13696998.2010.541045. Epub 2010 Dec 31.
7
Discrete event simulation: the preferred technique for health economic evaluations?离散事件模拟:健康经济评价的首选技术?
Value Health. 2010 Dec;13(8):1056-60. doi: 10.1111/j.1524-4733.2010.00775.x. Epub 2010 Sep 3.
8
Diabetes trends among delivery hospitalizations in the U.S., 1994-2004.美国 1994-2004 年分娩住院患者的糖尿病趋势。
Diabetes Care. 2010 Apr;33(4):768-73. doi: 10.2337/dc09-1801. Epub 2010 Jan 12.
9
Reliability and validity of birth certificate prepregnancy weight and height among women enrolled in prenatal WIC program: Florida, 2005.孕期妇女参加 WIC 计划时出生证明中孕前体重和身高的可靠性和有效性:佛罗里达州,2005 年。
Matern Child Health J. 2011 Oct;15(7):851-9. doi: 10.1007/s10995-009-0544-4.
10
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis.妊娠期糖尿病后患2型糖尿病:一项系统评价与荟萃分析
Lancet. 2009 May 23;373(9677):1773-9. doi: 10.1016/S0140-6736(09)60731-5.